• Allogenetics Appoints Dr. Jeroen Rovers as Chief Medical Officer

    Allogenetics Appoints Dr. Jeroen Rovers as Chief Medical Officer

    Seasoned executive leader and physician-scientist brings deep immunology and transplant medicine experience Company strengthens executive team as it advances its lead ex vivo donor-organ therapy ALG-115 toward clinical entry ALG-115 is designed to transform the treatment of graft rejection in lung transplantation Hanover, Germany, July 21, 2026 – Allogenetics today announced the appointment of Jeroen Rovers,…

    Continue Reading

About the Author

We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.